Research highlights: Targeted Protein Degradation in Tauopathies
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs